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aTo the Editor: The transition from the QRS complex to the
ST-segment on the 12-lead electrocardiogram (ECG) has been
conventionally termed the ST junction (STj). Occasionally, the
terminal portion of the QRS complex manifests a notch or slur
when transiting into the ST-segment. This has been described as
a normal variant in healthy individuals (1) in whom STj is very
often elevated. The term “early repolarization” has been used to
describe the latter phenomenon with or without end QRS notch-
ing or slurring (2).
Until recently, end QRS notching or slurring has generally been
considered benign. However, Haïssaguerre et al. (3) reported a
higher frequency of the early repolarization pattern in 206 survi-
vors of idiopathic ventricular fibrillation compared with 412
healthy controls matched for age, sex, race, and level of physical
activity. More recently, a “horizontal” ST-segment with or without
STj elevation, but with end QRS notching or slurring, has been
shown to have an important prognostic role (4,5).
Although numerous studies have investigated the benign and
athological significance of end QRS slurring or notching, there
re many inconsistencies in definitions. The goal of our study was
o explore the prevalence and demographic characteristics of QRS
nd notching or slurring and of associated STj amplitude in an
pparently healthy white population.
ECG recordings were obtained from 1,496 adults as previously
escribed (6). There were 859 males and 637 females, with a mean
ge of 37.4 12.6 years (range 18 to 82 years) overall (39.2 12.1
ears [range 18 to 82 years] for males and 35.1 12.9 years [range
8 to 71 years] for females). ECGs were analyzed with the widely
sed University of Glasgow ECG Analysis Program (7). Average
eats were calculated automatically and reviewed manually. STj
mplitude was measured in the inferior limb (II, III, and aVF),
Figure 1 Classification of Waveforms With J-Point Elevation on the 12-L
ECG  electrocardiogram; onQRSs  amplitude at the onset of a QRS slur; pkQRlateral limb (I and aVL), and lateral precordial (V4,V5, and V6)
leads using the program.
Different interpretations of “J-point elevation” were considered
and classified as shown in Figure 1. In the following definitions,
the amplitude of the peak of an end QRS notch is denoted
pkQRSn and the amplitude at the onset of a QRS slur is denoted
onQRSs. In this study, neither of these is regarded as QRS end
(STj).
• Type 1 pkQRSn 0.1 mV and STj 0.1 mV and
ST-segment upward sloping.
• Type 2 pkQRSn 0.1 mV and STj 0.1 mV.
• Type 3 onQRSs 0.1 mV and STj 0.1 mV and
ST-segment upward sloping.
• Type 4 onQRSs 0.1 mV and STj 0.1 mV.
• Type 5 No QRS notching or slurring and STj 0.1 mV and
ST-segment upward sloping.
The presence of these patterns in 2 contiguous inferior or lateral
leads was evaluated manually by 2 observers, who used the
automated STj measurement. V1 to V3 were excluded from the
analysis. A mixed type was defined by a mixture of types 1 to 4
with STj not exceeding 0.1 mV in 2 contiguous leads (i.e., a
combination of types 1 and 3 was not part of the mixed group).
All variations of J-point elevation in 2 contiguous leads other
than V1 to V3 occurred in 438 (29.3%) subjects. Table 1 shows the
revalence of J-point elevation. It was most prevalent in the
nferior leads whereas type 4 was the most frequently occurring.
-point elevation was more prevalent in inferior than in lateral limb
nd precordial leads (p  0.0001).
Across all age groups, J-point elevation patterns were more
prevalent in males (35.0% [301 of 859]) than females (21.5% [137
esting ECG
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September 4, 2012:947–9of 637]) (p  0.0001). This pattern persisted even when consid-
ering only those with associated ST-segment elevation: 0.5% (3 of
637) of females, 3.3% (28 of 859) of males (p  0.0001). In male
patients, there was a trend toward a lower prevalence of J-point
elevation patterns with increasing age. In female patients, the
reverse was true, although those with associated ST-segment
elevation were present only in the group aged 18 to 29 years.
Our results demonstrate that the prevalence of what has been
termed J-point elevation differs significantly according to the
inclusion (2.1%) or exclusion (29.3%) of STj elevation as defined in
this study. These data are strikingly similar to the results of Uberoi
et al. (8) in a slightly older VA population. Previous reports on
early repolarization that included ST-segment elevation as a
criterion found similar figures of 1% to 5% in the population (e.g., 2).
However, recent reports (e.g., 3) found a larger proportion of
healthy control subjects, ranging from 3% to 33%, manifesting end
QRS notching or slurring, which compares with our 29.3% with all
types of J-point elevation.
The prognostic value of J-point elevation in an apparently
healthy individual remains uncertain, as a significant proportion of
healthy control subjects from various studies exhibit this morphol-
ogy. Our results suggest that the exclusion of STj elevation from
J-point elevation may further decrease its specificity in healthy
individuals.
We have presented data on the prevalence of J-point elevation
with or without STj elevation in an apparently healthy white
population. These results have implications for studies looking at
the significance of J-point elevation and/or what is currently
termed early repolarization. In short, agreed definitions of J-point
elevation, STj, and ultimately what has been termed malignant
early repolarization (4) are required.
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Letters to the Editor
Potential Treatment Influences
and Mechanisms Related to
Asymmetric Dimethylarginine
Control in Heart Failure
We found the fascinating work presented by Shao et al. (1) to be
particularly compelling, as it highlights the physiological impact—and
potential clinical importance—of the endogenous nitric oxide syn-
thase inhibitor asymmetric dimethylarginine (ADMA) and dimethy-
larginine dimethylaminohydrolases (DDAHs) in patients with con-
gestive heart failure. Ongoing research has provided ample evidence
for the prognostic value of ADMA in the setting of cardiovascular
disease, and the enormous breadth of disorders with endothelial
dysfunction as a central component suggests a prominent role for
ADMA in vascular disease progression. By scrutinizing ADMA
production and metabolism paralleling vascular dysfunction with
subsequent heart failure, Shao et al. underscore the role of arginine
dysregulation and elevated ADMA in cardiovascular disease.
There are a few observations in their study (1), however, that warrant
further scrutiny. The authors report a significant treatment difference
between those with congestive heart failure and those with advanced
decompensated heart failure; the former exhibits high angiotensin-
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